Clinical trial
Special Drug Investigation of Kovaltry in Hemophilia A Patients
NCT02941783 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Special Drug Investigation of Kovaltry in Hemophilia A Patients
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2016
- Completion date
- September 9, 2025
- Enrollment
- 230 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.